Intrathecal and intraventricular morphine for pain in cancer patients: initial study
- 1 February 1982
- journal article
- research article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 56 (2), 241-245
- https://doi.org/10.3171/jns.1982.56.2.0241
Abstract
Intractable pain in 6 cancer patients was treated with lumbar intrathecal morphine (2 patients) and intraventricular morphine (4 patients). Daily percutaneous injections of morphine through Ommaya reservoirs were made. Initially, 1 mg of lumbar intrathecal morphine resulted in pain relief for 10-14 h and 2.5-4.0 mg of intraventricular morphine gave relief for 12-24 h. This treatment was continued for 3-7 mo. in 3 of the adults. Morphine requirements gradually increased. Side effects were minimal; there were no complications.This publication has 12 references indexed in Scilit:
- CNS Depression from Intrathecal MorphineAnesthesiology, 1980
- SELECTIVE SPINAL ANALGESIAThe Lancet, 1979
- SPINAL NARCOTICS AND RESPIRATORY DEPRESSIONThe Lancet, 1979
- Ommaya Reservoir PlacementNeurosurgery, 1979
- SELECTIVE SPINAL ANALGESIAThe Lancet, 1979
- Pain Relief by Intrathecally Applied Morphine in ManAnesthesiology, 1979
- Opiate receptor: autoradiographic localization in rat brain.Proceedings of the National Academy of Sciences, 1976
- Lamina-specific Suppression of Dorsal-horn Unit Activity by Morphine SulfateAnesthesiology, 1974
- Regional Distribution of Opiate Receptor Binding in Monkey and Human BrainNature, 1973